- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
GeneNews Acquires Full Control of Innovative Diagnostic Laboratory
GeneNews Limited (TSX:GEN) announced that it has entered into a Unit Purchase Agreement with Cobalt Healthcare Consultants, Inc., pursuant to which GeneNews’ wholly-owned subsidiary, GeneNews (USA), Inc., will acquire Cobalt’s 50% ownership interest in the Innovative Diagnostic Laboratory, LLP joint-venture. Once concluded, GeneNews will have full ownership of IDL.
GeneNews Limited (TSX:GEN) announced that it has entered into a Unit Purchase Agreement with Cobalt Healthcare Consultants, Inc., pursuant to which GeneNews’ wholly-owned subsidiary, GeneNews (USA), Inc., will acquire Cobalt’s 50% ownership interest in the Innovative Diagnostic Laboratory, LLP joint-venture. Once concluded, GeneNews will have full ownership of IDL.
According to the news:
Under terms of the Purchasing Agreement, GeneNews will assume any and all of Cobalt’s liability relating to Cobalt’s $US 1 million Secured Demand Promissory Note (the “Note”) payable to former IDL partner, HDL USA Holdings, LLC. No other consideration will be paid. Additionally, GeneNews has asked for and received a one year extension on the term of the Note, making it due in May 2017. The Purchasing Agreement is subject to GeneNews completing a strategic financing during March 2016.
GeneNews’ Executive Chairman, James Howard-Tripp commented:
In recent months, we have taken a number of important steps to get the Company on a more solid footing to support an orderly restructuring of its operations. With a number of difficult decisions behind us, and this Purchasing Agreement in place, we are now much better prepared to pursue the working capital we need to restore IDL’s corporate viability and re-establish its growth trajectory.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.